Document is current
Any future updates will be listed below
-
Authors
Leshem, Yasmin
Golomb, Inbal
Zubkov, Asia
Bar, Yael
Strulov Shachar, Shlomit
Lerner, Shir
Keren-Khadmy, Noa
Sonnenblick, Amir
-
Funding
Funding for this research was provided by:
Tel Aviv University
- License Information
-
More Information
Article History
Received: 30 December 2025
Accepted: 11 March 2026
First Online: 11 April 2026
Declarations
:
: Amir Sonnenblick reports a relationship with Eli Lilly that includes: consulting or advisory. Amir Sonnenblick reports a relationship with Novartis that includes: consulting or advisory, funding grants, and speaking and lecture fees. Amir Sonnenblick reports a relationship with Roche that includes: consulting or advisory, funding grants, speaking and lecture fees, and travel reimbursement. Amir Sonnenblick reports a relationship with Stemline Therapeutics Inc that includes: consulting or advisory, speaking and lecture fees, and travel reimbursement. Amir Sonnenblick reports a relationship with Pfizer that includes: travel reimbursement. Amir Sonnenblick reports a relationship with Progenetics that includes: speaking and lecture fees. Amir Sonnenblick reports a relationship with Gilead Sciences Inc that includes: funding grants and speaking and lecture fees. Amir Sonnenblick reports a relationship with Merck & Co Inc that includes. Yasmin Leshem reports a relationship with Novartis that includes: consulting or advisory and speaking and lecture fees. Yasmin Leshem reports a relationship with Eli Lilly that includes: consulting or advisory. Yasmin Leshem reports a relationship with Gilead Sciences Inc that includes: travel reimbursement. Yael Bar reports a relationship with Stemline Therapeutics Inc that includes: speaking and lecture fees. Yael Bar reports a relationship with Eli Lilly and Company that includes: consulting or advisory and speaking and lecture fees. Yael Bar reports a relationship with Roche that includes: speaking and lecture fees and travel reimbursement. Yael Bar reports a relationship with Gilead Sciences Inc that includes: speaking and lecture fees. Yael bar reports a relationship with Pfizer Inc that includes: speaking and lecture fees. Yael Bar reports a relationship with Novartis that includes: consulting or advisory and speaking and lecture fees. Yael Bar reports a relationship with Astra zeneca that includes: speaking and lecture fees. If there are other authors, they declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
